[go: up one dir, main page]

Sukavaneshvar, 2008 - Google Patents

Assessment and management of vascular implant thrombogenecity

Sukavaneshvar, 2008

Document ID
14317494143019564560
Author
Sukavaneshvar S
Publication year
Publication venue
Thrombus and Stroke. New York, NY: Informa Health Care

External Links

Snippet

Vascular implants such as stents and coils have been used successfully to treat diseases such as atherosclerosis and aneurysms (1-3). These devices, however, carry the risk of thrombosis, which warrants consideration during device design and during clinical …
Continue reading at books.google.com (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • G01N33/4905Determining clotting time of blood
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/22Haematology
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans

Similar Documents

Publication Publication Date Title
Fink et al. Real-time measurements of coagulation on bacterial cellulose and conventional vascular graft materials
Chinn et al. Baboon fibrinogen adsorption and platelet adhesion to polymeric materials
JP2021012207A (en) Detection and classification of anticoagulant using clotting assay
US10830683B2 (en) Method for measuring coagulation of blood samples using viscoelastic tests (VET)
Lasne et al. A Study of Platelet Functions with a New Analyzer Using High Shear Stress (PFA100™) in Patients Undergoing Coronary Artery Bypass Graft
US20050196748A1 (en) Method and device for monitoring platelet function
Grunkemeier et al. Co-adsorbed fibrinogen and von Willebrand factor augment platelet procoagulant activity and spreading
Kottke‐Marchant et al. Vascular graft‐associated complement activation and leukocyte adhesion in an artificial circulation
Braune et al. Developing standards and test protocols for testing the hemocompatibility of biomaterials
Sperling et al. Test methods for hemocompatibility of biomaterials
McKenzie et al. Clinical utility of available methods for determining platelet function
Mrowietz et al. Haemocompatibility of polymer‐coated stainless steel stents as compared to uncoated stents
Massicotte et al. Antithrombotic therapy for ventricular assist devices in children: do we really know what to do?
US10012659B2 (en) Methods for diagnosing iron-related pathologies
Bauer et al. Influence of blood collection technique on platelet function and coagulation variables in dogs
US20050019742A1 (en) Methods for assessment of platelet aggregation
Sukavaneshvar Assessment and management of vascular implant thrombogenecity
Krajewski et al. Real-time measurement of free thrombin: evaluation of the usability of a new thrombin assay for coagulation monitoring during extracorporeal circulation
Wakhloo et al. Assessment and Management of Vascular Implant Thrombogenecity...................................... Sivaprasad Sukavaneshvar
Patel et al. Molecular biomarkers for In vitro thrombogenicity assessment of medical device materials
Abe et al. Correlation between platelet thrombus formation on collagen-coated beads and platelet aggregation induced by ADP
Berkowitz et al. Progress in point-of-care laboratory testing for assessing platelet function
Adams Platelet adhesion: past and present
JP4833727B2 (en) Thrombus monitoring method and thrombus monitoring apparatus using vascular endothelial cells
Mischke Laboratory evaluation and interpretation of haemostasis in small animals